JP Morgan Chase’s GoodRx Holdings GDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding GDRX
FPM
SLG
PTC
JP Morgan Chase's GDRX Position: Q2 2026 in Review
JP Morgan Chase increased its GoodRx Holdings (GDRX) stake by 255% in Q2 2026, buying an estimated $6.48K and bringing the position to 3,549 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6914.
JP Morgan Chase first reported a position in GDRX in Q3 2020 and has held it in 24 quarters since. The position peaked at $49.5M in Q3 2020. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.
- JP Morgan Chase held 3,549 shares of GoodRx Holdings worth $10.1K as of Q2 2026.
- JP Morgan Chase bought 2,549 GoodRx Holdings shares in Q2 2026, an estimated $6.48K.
- GoodRx Holdings made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6914 holding.
- JP Morgan Chase first reported a position in GoodRx Holdings in Q3 2020 and has held it in 24 quarters since.
- JP Morgan Chase's GoodRx Holdings position peaked at $49.5M in Q3 2020.
- 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.